- Trump announced Medicaid deals with nine midsize drugmakers (bringing the total to 26 companies) to charge Medicaid the same low prices they charge abroad — “lowest prices available anywhere in the world,” the White House said.
- In exchange the companies get exemptions from similar Medicare “most favored nation” programs and tariff protection, and they pledged roughly $19.6 billion in U.S. manufacturing investment.
- The White House claims up to $64.3 billion in savings over a decade, but critics say the secretive deals are speculative, may not help the 160+ million with employer insurance, and the real impact is unclear.
The news, distilled into what matters.
Get the full experience in the app — topics, comments, and audio summaries.